Satu Långström MD, P., Minna Koskenvuo MD, P., Pasi Huttunen MD, P., Riitta Lassila MD, P., Mervi Taskinen MD, P., Susanna Ranta MD, P., . . . Anne Mäkipernaa MD, P. Graft-Versus-Host Disease Sustains Coagulation Activity for two Years After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. SAGE Publishing.
Chicago Style (17th ed.) CitationSatu Långström MD, PhD, PhD Minna Koskenvuo MD, PhD Pasi Huttunen MD, PhD Riitta Lassila MD, PhD Mervi Taskinen MD, PhD Susanna Ranta MD, PhD Markku Heikinheimo MD, and PhD Anne Mäkipernaa MD. Graft-Versus-Host Disease Sustains Coagulation Activity for Two Years After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. SAGE Publishing.
MLA (9th ed.) CitationSatu Långström MD, PhD, et al. Graft-Versus-Host Disease Sustains Coagulation Activity for Two Years After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. SAGE Publishing.